{"transactions":[{"id":1858751,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2023-06-12T20:10:53.000Z","date":"2023-06-09","kind":"grant","planned":false,"acquired":true,"shares":29532,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest in full upon the first anniversary of the date of grant  or, if earlier, the day immediately before the date of the next annual meeting of stockholders that occurs after the grant date, subject to the Reporting Person continuing to be a service provider to the Issuer through each applicable vesting date."}],"balance_after":29532,"derivative":{"exercise_price":7.12,"exercise_date":"2024-06-09","expiration_date":"2033-06-08","underlying":"Common Stock","underlying_shares":29532},"source":{"system":"sec-edgar","filing":"0001209191-23-036506","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919123036506/doc4.xml","form_type":"4"}},{"id":1969085,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-06T17:05:40.000Z","date":"2023-03-02","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/2 of the shares subject to the stock option vest on the first anniversary of the grant date of March 2, 2023 (the \"2023 Grant Date\"), and the remaining 1/2 of the shares vest on the second anniversary of the 2023 Grant Date."}],"balance_after":175000,"derivative":{"exercise_price":4.36,"expiration_date":"2033-03-01","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001209191-23-016384","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919123016384/doc4.xml","form_type":"4"}},{"id":1969084,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-06T17:05:40.000Z","date":"2023-03-02","kind":"grant","acquired":true,"shares":192000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the stock option vest over a four-year period commencing January 1, 2023, with 1/48th of the shares vesting on a monthly basis."}],"balance_after":192000,"derivative":{"exercise_price":4.36,"expiration_date":"2033-03-01","underlying":"Common Stock","underlying_shares":192000},"source":{"system":"sec-edgar","filing":"0001209191-23-016384","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919123016384/doc4.xml","form_type":"4"}},{"id":1969083,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-03-06T17:05:40.000Z","date":"2023-03-02","kind":"grant","acquired":true,"shares":64000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issuable upon the vesting and settlement of restricted stock units (\"RSUs\"). 1/4th of the RSUs vest on each of January 15, 2024, January 15, 2025, January 15, 2026 and January 15, 2027."}],"balance_after":972893,"source":{"system":"sec-edgar","filing":"0001209191-23-016384","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919123016384/doc4.xml","form_type":"4"}},{"id":2052447,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-18T16:06:31.000Z","date":"2023-01-17","kind":"exercise","acquired":false,"shares":85082,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise occurred because the option was expiring, and shares were sold to pay the exercise price and related tax obligations."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":1.44,"expiration_date":"2023-01-23","underlying":"Common Stock","underlying_shares":85082},"source":{"system":"sec-edgar","filing":"0001209191-23-003702","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919123003702/doc4.xml","form_type":"4"}},{"id":2052446,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-01-18T16:06:31.000Z","date":"2023-01-17","kind":"sale","acquired":false,"shares":85082,"price":5.1516,"value":438308.4312,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise occurred because the option was expiring, and shares were sold to pay the exercise price and related tax obligations."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $5.015 to $5.30. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":908893,"source":{"system":"sec-edgar","filing":"0001209191-23-003702","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919123003702/doc4.xml","form_type":"4"}},{"id":2052445,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-01-18T16:06:31.000Z","date":"2023-01-17","kind":"exercise","acquired":true,"shares":85082,"price":1.44,"value":122518.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise occurred because the option was expiring, and shares were sold to pay the exercise price and related tax obligations."}],"balance_after":993975,"source":{"system":"sec-edgar","filing":"0001209191-23-003702","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919123003702/doc4.xml","form_type":"4"}},{"id":2234160,"issuer":{"id":6506,"kind":"organization","name":"Tenaya Therapeutics, Inc.","symbol":"TNYA"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2022-06-13T20:49:03.000Z","date":"2022-06-10","kind":"grant","acquired":true,"shares":39727,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option granted pursuant to the Tenaya Therapeutics, Inc. 2021 Equity Incentive Plan. Option will vest in full upon the first anniversary of the date of grant  or, if earlier, the day immediately before the date of the next annual meeting of stockholders that occurs after the grant date, subject to the Reporting Person continuing to be a service provider to the Issuer through each applicable vesting date."}],"balance_after":39727,"derivative":{"exercise_price":5.26,"exercise_date":"2023-06-10","expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":39727},"source":{"system":"sec-edgar","filing":"0001209191-22-036523","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919122036523/doc4.xml","form_type":"4"}},{"id":2350321,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-04T16:09:21.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the stock option vest over a four-year period commencing January 1, 2022, with 1/48th of the shares vesting on a monthly basis."}],"balance_after":175000,"derivative":{"exercise_price":15.2,"expiration_date":"2032-03-02","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001209191-22-016205","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919122016205/doc4.xml","form_type":"4"}},{"id":2482260,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-07T21:54:25.000Z","date":"2021-12-06","kind":"exercise","acquired":false,"shares":69444,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully vested."}],"balance_after":85082,"derivative":{"exercise_price":1.44,"expiration_date":"2023-01-23","underlying":"Common Stock","underlying_shares":69444},"source":{"system":"sec-edgar","filing":"0001209191-21-068466","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919121068466/doc4.xml","form_type":"4"}},{"id":2482259,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-12-07T21:54:25.000Z","date":"2021-12-07","kind":"sale","acquired":false,"shares":15000,"price":18.6,"value":279000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 6, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $18.10 to $18.99. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":908893,"source":{"system":"sec-edgar","filing":"0001209191-21-068466","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919121068466/doc4.xml","form_type":"4"}},{"id":2482258,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-12-07T21:54:25.000Z","date":"2021-12-06","kind":"exercise","acquired":true,"shares":69444,"price":1.44,"value":99999.36,"ownership":{"direct":true},"balance_after":923893,"source":{"system":"sec-edgar","filing":"0001209191-21-068466","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919121068466/doc4.xml","form_type":"4"}},{"id":2482257,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-12-07T21:54:25.000Z","date":"2021-12-06","kind":"sale","acquired":false,"shares":15000,"price":18.21,"value":273150.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 6, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $17.79 to $18.49. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":854449,"source":{"system":"sec-edgar","filing":"0001209191-21-068466","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919121068466/doc4.xml","form_type":"4"}},{"id":2510641,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-11-16T18:09:11.000Z","date":"2021-11-15","kind":"sale","acquired":false,"shares":15000,"price":19.56,"value":293400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 6, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $19.29 to $19.90. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":869449,"source":{"system":"sec-edgar","filing":"0001209191-21-064853","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919121064853/doc4.xml","form_type":"4"}},{"id":2510640,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-11-16T18:09:11.000Z","date":"2021-11-15","kind":"sale","acquired":false,"shares":15000,"price":19.89,"value":298350.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 6, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $19.66 to $20.24. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":884449,"source":{"system":"sec-edgar","filing":"0001209191-21-064853","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919121064853/doc4.xml","form_type":"4"}},{"id":2543395,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-10-13T16:34:52.000Z","date":"2021-10-12","kind":"sale","acquired":false,"shares":15000,"price":20.14,"value":302100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 6, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $19.91 to $20.52. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":899449,"source":{"system":"sec-edgar","filing":"0001209191-21-060364","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919121060364/doc4.xml","form_type":"4"}},{"id":2543394,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-10-13T16:34:52.000Z","date":"2021-10-11","kind":"sale","acquired":false,"shares":15000,"price":20.41,"value":306150.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 6, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $19.75 to $20.66. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":914449,"source":{"system":"sec-edgar","filing":"0001209191-21-060364","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919121060364/doc4.xml","form_type":"4"}},{"id":2570758,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-09-14T21:27:48.000Z","date":"2021-09-14","kind":"sale","acquired":false,"shares":3037,"price":26.13,"value":79356.81,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 6, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $26.05 to $26.19. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":929449,"source":{"system":"sec-edgar","filing":"0001209191-21-056083","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919121056083/doc4.xml","form_type":"4"}},{"id":2570757,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-09-14T21:27:48.000Z","date":"2021-09-14","kind":"sale","acquired":false,"shares":11963,"price":25.54,"value":305535.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 6, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $25.04 to $26.02. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":932486,"source":{"system":"sec-edgar","filing":"0001209191-21-056083","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919121056083/doc4.xml","form_type":"4"}},{"id":2570756,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-09-14T21:27:48.000Z","date":"2021-09-13","kind":"sale","acquired":false,"shares":170,"price":26.98,"value":4586.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 6, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $26.92 to $27.07. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":944449,"source":{"system":"sec-edgar","filing":"0001209191-21-056083","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919121056083/doc4.xml","form_type":"4"}},{"id":2570755,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-09-14T21:27:48.000Z","date":"2021-09-13","kind":"sale","acquired":false,"shares":10910,"price":26.17,"value":285514.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 6, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $25.82 to $26.77. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":944619,"source":{"system":"sec-edgar","filing":"0001209191-21-056083","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919121056083/doc4.xml","form_type":"4"}},{"id":2570754,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-09-14T21:27:48.000Z","date":"2021-09-13","kind":"sale","acquired":false,"shares":3920,"price":25.59,"value":100312.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 6, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $24.82 to $25.81. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":955529,"source":{"system":"sec-edgar","filing":"0001209191-21-056083","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919121056083/doc4.xml","form_type":"4"}},{"id":2606858,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-08-11T18:48:34.000Z","date":"2021-08-10","kind":"sale","acquired":false,"shares":15000,"price":23.15,"value":347250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 6, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $22.86 to $23.75. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":959449,"source":{"system":"sec-edgar","filing":"0001209191-21-050981","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919121050981/doc4.xml","form_type":"4"}},{"id":2606857,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-08-11T18:48:34.000Z","date":"2021-08-09","kind":"sale","acquired":false,"shares":600,"price":25.62,"value":15372.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 6, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $25.52 to $25.91. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":974449,"source":{"system":"sec-edgar","filing":"0001209191-21-050981","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919121050981/doc4.xml","form_type":"4"}},{"id":2606856,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-08-11T18:48:34.000Z","date":"2021-08-09","kind":"sale","acquired":false,"shares":6669,"price":25.12,"value":167525.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 6, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $24.49 to $25.46. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":975049,"source":{"system":"sec-edgar","filing":"0001209191-21-050981","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919121050981/doc4.xml","form_type":"4"}},{"id":2606855,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-08-11T18:48:34.000Z","date":"2021-08-09","kind":"sale","acquired":false,"shares":7731,"price":23.81,"value":184075.11,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 6, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $23.44 to $24.29. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":981718,"source":{"system":"sec-edgar","filing":"0001209191-21-050981","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919121050981/doc4.xml","form_type":"4"}},{"id":2679340,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-07T16:49:41.000Z","date":"2021-06-03","kind":"exercise","acquired":false,"shares":69444,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":1.44,"expiration_date":"2022-03-01","underlying":"Common Stock","underlying_shares":69444},"source":{"system":"sec-edgar","filing":"0001209191-21-038655","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919121038655/doc4.xml","form_type":"4"}},{"id":2679339,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-06-07T16:49:41.000Z","date":"2021-06-03","kind":"exercise","acquired":true,"shares":69444,"price":1.44,"value":99999.36,"ownership":{"direct":true},"balance_after":989449,"source":{"system":"sec-edgar","filing":"0001209191-21-038655","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919121038655/doc4.xml","form_type":"4"}},{"id":2730170,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-05-04T16:39:12.000Z","date":"2021-05-03","kind":"sale","acquired":false,"shares":25000,"price":27.62,"value":690500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $27.12 to $27.90. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":920005,"source":{"system":"sec-edgar","filing":"0001209191-21-029913","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919121029913/doc4.xml","form_type":"4"}},{"id":2750411,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-04-13T18:56:44.000Z","date":"2021-04-12","kind":"sale","acquired":false,"shares":25000,"price":24.65,"value":616250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $24.30 to $25.20. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":945005,"source":{"system":"sec-edgar","filing":"0001209191-21-026503","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919121026503/doc4.xml","form_type":"4"}},{"id":2779290,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-18T20:25:13.000Z","date":"2021-03-17","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the stock option vest over a four-year period commencing January 1, 2021, with 1/48th of the shares vesting on a monthly basis."}],"balance_after":175000,"derivative":{"exercise_price":31.93,"expiration_date":"2031-03-16","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001209191-21-021932","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919121021932/doc4.xml","form_type":"4"}},{"id":2820139,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-03-02T17:19:17.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":25000,"price":26.66,"value":666500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $26.22 to $27.00. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":970005,"source":{"system":"sec-edgar","filing":"0001209191-21-016231","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919121016231/doc4.xml","form_type":"4"}},{"id":2854658,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-02-17T16:19:42.000Z","date":"2021-02-16","kind":"sale","acquired":false,"shares":25000,"price":28.75,"value":718750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $28.528 to $29.31. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":995005,"source":{"system":"sec-edgar","filing":"0001209191-21-011253","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919121011253/doc4.xml","form_type":"4"}},{"id":2915765,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-06T19:30:41.000Z","date":"2021-01-05","kind":"exercise","acquired":false,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to its terms, the option to purchase these shares expires on February 10, 2021, unless earlier exercised. This transaction represents the exercise of the shares under this incentive stock option by the reporting person prior to the expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":0.6,"expiration_date":"2021-02-10","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-21-002374","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919121002374/doc4.xml","form_type":"4"}},{"id":2915764,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-01-06T19:30:41.000Z","date":"2021-01-05","kind":"exercise","acquired":true,"shares":150000,"price":0.6,"value":90000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to its terms, the option to purchase these shares expires on February 10, 2021, unless earlier exercised. This transaction represents the exercise of the shares under this incentive stock option by the reporting person prior to the expiration date."}],"balance_after":1020005,"source":{"system":"sec-edgar","filing":"0001209191-21-002374","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919121002374/doc4.xml","form_type":"4"}},{"id":2915763,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-01-06T19:30:41.000Z","date":"2021-01-04","kind":"sale","acquired":false,"shares":370,"price":30.26,"value":11196.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2020."}],"balance_after":870005,"source":{"system":"sec-edgar","filing":"0001209191-21-002374","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919121002374/doc4.xml","form_type":"4"}},{"id":2915762,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-01-06T19:30:41.000Z","date":"2021-01-04","kind":"sale","acquired":false,"shares":24630,"price":29.27,"value":720920.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $28.945 to $29.56. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":870375,"source":{"system":"sec-edgar","filing":"0001209191-21-002374","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919121002374/doc4.xml","form_type":"4"}},{"id":2942586,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-12-16T16:34:18.000Z","date":"2020-12-14","kind":"sale","acquired":false,"shares":3145,"price":28.89,"value":90859.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $28.80 to $29.50. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":895005,"source":{"system":"sec-edgar","filing":"0001209191-20-063799","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919120063799/doc4.xml","form_type":"4"}},{"id":2942585,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-12-16T16:34:18.000Z","date":"2020-12-14","kind":"sale","acquired":false,"shares":10729,"price":28.19,"value":302450.51,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $27.79 to $28.78. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":898150,"source":{"system":"sec-edgar","filing":"0001209191-20-063799","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919120063799/doc4.xml","form_type":"4"}},{"id":2942584,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-12-16T16:34:18.000Z","date":"2020-12-14","kind":"sale","acquired":false,"shares":11126,"price":27.59,"value":306966.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $26.76 to $27.74. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":908879,"source":{"system":"sec-edgar","filing":"0001209191-20-063799","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919120063799/doc4.xml","form_type":"4"}},{"id":2992856,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-11-04T17:10:40.000Z","date":"2020-11-02","kind":"sale","acquired":false,"shares":25000,"price":17.7,"value":442500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $17.355 to $17.79. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":920005,"source":{"system":"sec-edgar","filing":"0001209191-20-056934","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919120056934/doc4.xml","form_type":"4"}},{"id":3008291,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-10-13T17:52:25.000Z","date":"2020-10-12","kind":"sale","acquired":false,"shares":25000,"price":17.02,"value":425500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $16.79 to $17.46. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":945005,"source":{"system":"sec-edgar","filing":"0001209191-20-054708","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919120054708/doc4.xml","form_type":"4"}},{"id":3039302,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-09-03T16:18:58.000Z","date":"2020-09-01","kind":"sale","acquired":false,"shares":7613,"price":18.32,"value":139470.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.94. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":970005,"source":{"system":"sec-edgar","filing":"0001209191-20-049387","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919120049387/doc4.xml","form_type":"4"}},{"id":3039301,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-09-03T16:18:58.000Z","date":"2020-09-01","kind":"sale","acquired":false,"shares":17387,"price":17.62,"value":306358.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $17.28 to $17.98. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":977618,"source":{"system":"sec-edgar","filing":"0001209191-20-049387","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919120049387/doc4.xml","form_type":"4"}},{"id":3061867,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-08-11T16:30:16.000Z","date":"2020-08-10","kind":"sale","acquired":false,"shares":25000,"price":19.02,"value":475500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $18.77 to $19.425. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":995005,"source":{"system":"sec-edgar","filing":"0001209191-20-046128","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919120046128/doc4.xml","form_type":"4"}},{"id":3091908,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-07-02T16:36:43.000Z","date":"2020-07-01","kind":"sale","acquired":false,"shares":7263,"price":19.2,"value":139449.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $19.10 to $19.315. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":1020005,"source":{"system":"sec-edgar","filing":"0001209191-20-040351","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919120040351/doc4.xml","form_type":"4"}},{"id":3091907,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-07-02T16:36:43.000Z","date":"2020-07-01","kind":"sale","acquired":false,"shares":17737,"price":18.79,"value":333278.23,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $18.105 to $19.095. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":1027268,"source":{"system":"sec-edgar","filing":"0001209191-20-040351","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919120040351/doc4.xml","form_type":"4"}},{"id":3107114,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-06-17T18:31:07.000Z","date":"2020-06-15","kind":"sale","acquired":false,"shares":19400,"price":21.79,"value":422726.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $21.45 to $22.06. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,562 shares purchased through the Issuer's ESPP on November 15, 2019."}],"balance_after":1045005,"source":{"system":"sec-edgar","filing":"0001209191-20-037406","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919120037406/doc4.xml","form_type":"4"}},{"id":3107113,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-06-17T18:31:07.000Z","date":"2020-06-15","kind":"sale","acquired":false,"shares":5600,"price":21.15,"value":118440.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $20.44 to $21.435. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,562 shares purchased through the Issuer's ESPP on November 15, 2019."}],"balance_after":1064405,"source":{"system":"sec-edgar","filing":"0001209191-20-037406","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919120037406/doc4.xml","form_type":"4"}},{"id":3286568,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-06T20:04:03.000Z","date":"2020-02-04","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the stock option vest over a four-year period commencing January 1, 2020, with 1/48th of the shares vesting on a monthly basis."}],"balance_after":175000,"derivative":{"exercise_price":16.47,"expiration_date":"2030-02-03","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001209191-20-007326","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919120007326/doc4.xml","form_type":"4"}},{"id":3314543,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-09T19:26:39.000Z","date":"2020-01-09","kind":"exercise","acquired":false,"shares":18641,"price":1.44,"value":26843.04,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The shares subject to the stock option are fully vested."}],"balance_after":154526,"derivative":{"exercise_price":1.44,"expiration_date":"2023-01-23","underlying":"Common Stock","underlying_shares":173167},"source":{"system":"sec-edgar","filing":"0001209191-20-002910","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919120002910/doc4.xml","form_type":"4"}},{"id":3314542,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-09T19:26:39.000Z","date":"2020-01-08","kind":"exercise","acquired":false,"shares":71750,"price":0.52,"value":37310.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The shares subject to the stock option are fully vested."}],"balance_after":0,"derivative":{"exercise_price":0.52,"expiration_date":"2020-02-24","underlying":"Common Stock","underlying_shares":71750},"source":{"system":"sec-edgar","filing":"0001209191-20-002910","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919120002910/doc4.xml","form_type":"4"}},{"id":3314541,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-09T19:26:39.000Z","date":"2020-01-08","kind":"exercise","acquired":false,"shares":1833,"price":1.44,"value":2639.52,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The shares subject to the stock option are fully vested."}],"balance_after":173167,"derivative":{"exercise_price":1.44,"expiration_date":"2023-01-23","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001209191-20-002910","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919120002910/doc4.xml","form_type":"4"}},{"id":3314540,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-09T19:26:39.000Z","date":"2020-01-08","kind":"exercise","acquired":false,"shares":14201,"price":1.44,"value":20449.44,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The shares subject to the stock option are fully vested."}],"balance_after":69444,"derivative":{"exercise_price":1.44,"expiration_date":"2022-03-01","underlying":"Common Stock","underlying_shares":83645},"source":{"system":"sec-edgar","filing":"0001209191-20-002910","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919120002910/doc4.xml","form_type":"4"}},{"id":3314539,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-09T19:26:39.000Z","date":"2020-01-07","kind":"exercise","acquired":false,"shares":16090,"price":1.44,"value":23169.6,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The shares subject to the stock option are fully vested."}],"balance_after":83645,"derivative":{"exercise_price":1.44,"expiration_date":"2022-03-01","underlying":"Common Stock","underlying_shares":99735},"source":{"system":"sec-edgar","filing":"0001209191-20-002910","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919120002910/doc4.xml","form_type":"4"}},{"id":3314538,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-01-09T19:26:39.000Z","date":"2020-01-09","kind":"sale","acquired":false,"shares":18641,"price":17.9501,"value":334607.8141,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"The reporting person sold 18,641 shares of common stock in anticipation of a potential alternative minimum tax liability resulting from his exercise of a portion of an incentive stock option covering 71,750 shares of common stock on January 9, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $17.74 to $18.385. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":1068443,"source":{"system":"sec-edgar","filing":"0001209191-20-002910","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919120002910/doc4.xml","form_type":"4"}},{"id":3314537,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-01-09T19:26:39.000Z","date":"2020-01-09","kind":"exercise","acquired":true,"shares":18641,"price":1.44,"value":26843.04,"ownership":{"direct":true},"balance_after":1087084,"source":{"system":"sec-edgar","filing":"0001209191-20-002910","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919120002910/doc4.xml","form_type":"4"}},{"id":3314536,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-01-09T19:26:39.000Z","date":"2020-01-08","kind":"exercise","acquired":true,"shares":71750,"price":0.52,"value":37310.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Pursuant to its terms, the option to purchase these shares expires on February 24, 2020, unless earlier exercised.  This transaction represents the exercise of the remaining shares under this incentive stock option by the reporting person prior to the expiration date."}],"balance_after":1068443,"source":{"system":"sec-edgar","filing":"0001209191-20-002910","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919120002910/doc4.xml","form_type":"4"}},{"id":3314535,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-01-09T19:26:39.000Z","date":"2020-01-08","kind":"sale","acquired":false,"shares":1833,"price":17.9798,"value":32956.9734,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The reporting person sold 1,833 shares of common stock in anticipation of a potential alternative minimum tax liability resulting from his exercise of a portion of an incentive stock option covering 71,750 shares of common stock on January 8, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $17.59 to $18.50. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":996693,"source":{"system":"sec-edgar","filing":"0001209191-20-002910","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919120002910/doc4.xml","form_type":"4"}},{"id":3314534,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-01-09T19:26:39.000Z","date":"2020-01-08","kind":"exercise","acquired":true,"shares":1833,"price":1.44,"value":2639.52,"ownership":{"direct":true},"balance_after":998526,"source":{"system":"sec-edgar","filing":"0001209191-20-002910","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919120002910/doc4.xml","form_type":"4"}},{"id":3314533,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-01-09T19:26:39.000Z","date":"2020-01-08","kind":"sale","acquired":false,"shares":14201,"price":17.9798,"value":255331.1398,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The reporting person sold 14,021 shares of common stock in anticipation of a potential alternative minimum tax liability resulting from his exercise of a portion of an incentive stock option covering 71,750 shares of common stock on January 8, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $17.59 to $18.50. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":996693,"source":{"system":"sec-edgar","filing":"0001209191-20-002910","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919120002910/doc4.xml","form_type":"4"}},{"id":3314532,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-01-09T19:26:39.000Z","date":"2020-01-08","kind":"exercise","acquired":true,"shares":14201,"price":1.44,"value":20449.44,"ownership":{"direct":true},"balance_after":1010894,"source":{"system":"sec-edgar","filing":"0001209191-20-002910","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919120002910/doc4.xml","form_type":"4"}},{"id":3314531,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-01-09T19:26:39.000Z","date":"2020-01-07","kind":"sale","acquired":false,"shares":16090,"price":18.2024,"value":292876.616,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person sold 16,090 shares of common stock in anticipation of a potential alternative minimum tax liability resulting from his exercise of a portion of an incentive stock option covering 71,750 shares of common stock on January 7, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $17.93 to $18.44. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":996693,"source":{"system":"sec-edgar","filing":"0001209191-20-002910","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919120002910/doc4.xml","form_type":"4"}},{"id":3314530,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-01-09T19:26:39.000Z","date":"2020-01-07","kind":"exercise","acquired":true,"shares":16090,"price":1.44,"value":23169.6,"ownership":{"direct":true},"balance_after":1012783,"source":{"system":"sec-edgar","filing":"0001209191-20-002910","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919120002910/doc4.xml","form_type":"4"}},{"id":3382130,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-11-04T18:06:30.000Z","date":"2019-11-04","kind":"exercise","acquired":false,"shares":10986,"price":1.44,"value":15819.84,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"All shares underlying this option have vested."}],"balance_after":99735,"derivative":{"exercise_price":1.44,"expiration_date":"2022-03-01","underlying":"Common Stock","underlying_shares":110721},"source":{"system":"sec-edgar","filing":"0001209191-19-055021","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919119055021/doc4.xml","form_type":"4"}},{"id":3382129,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-11-04T18:06:30.000Z","date":"2019-11-01","kind":"exercise","acquired":false,"shares":71750,"price":0.52,"value":37310.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"All shares underlying this option have vested."}],"balance_after":71750,"derivative":{"exercise_price":0.52,"expiration_date":"2020-02-24","underlying":"Common Stock","underlying_shares":143500},"source":{"system":"sec-edgar","filing":"0001209191-19-055021","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919119055021/doc4.xml","form_type":"4"}},{"id":3382128,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-11-04T18:06:30.000Z","date":"2019-11-01","kind":"exercise","acquired":false,"shares":11403,"price":1.44,"value":16420.32,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"All shares underlying this option have vested."}],"balance_after":110721,"derivative":{"exercise_price":1.44,"expiration_date":"2022-03-01","underlying":"Common Stock","underlying_shares":122124},"source":{"system":"sec-edgar","filing":"0001209191-19-055021","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919119055021/doc4.xml","form_type":"4"}},{"id":3382127,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-11-04T18:06:30.000Z","date":"2019-10-31","kind":"exercise","acquired":false,"shares":28376,"price":1.44,"value":40861.44,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"All shares underlying this option have vested."}],"balance_after":122124,"derivative":{"exercise_price":1.44,"expiration_date":"2022-03-01","underlying":"Common Stock","underlying_shares":150500},"source":{"system":"sec-edgar","filing":"0001209191-19-055021","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919119055021/doc4.xml","form_type":"4"}},{"id":3382126,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-11-04T18:06:30.000Z","date":"2019-11-04","kind":"sale","acquired":false,"shares":10986,"price":12.2605,"value":134693.853,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"The reporting person sold 10,986 shares of common stock in anticipation of a potential alternative minimum tax liability resulting from his exercise of a portion of an incentive stock option covering 71,750 shares of common stock on November 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $12.04 to $12.76. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":996693,"source":{"system":"sec-edgar","filing":"0001209191-19-055021","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919119055021/doc4.xml","form_type":"4"}},{"id":3382125,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-11-04T18:06:30.000Z","date":"2019-11-04","kind":"exercise","acquired":true,"shares":10986,"price":1.44,"value":15819.84,"ownership":{"direct":true},"balance_after":1007679,"source":{"system":"sec-edgar","filing":"0001209191-19-055021","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919119055021/doc4.xml","form_type":"4"}},{"id":3382124,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-11-04T18:06:30.000Z","date":"2019-11-01","kind":"exercise","acquired":true,"shares":71750,"price":0.52,"value":37310.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Pursuant to its terms, the option to purchase these shares expires on February 24, 2020, unless earlier exercised.  This transaction represents the exercise of a portion of this incentive stock option by the reporting person prior to the expiration date."}],"balance_after":996693,"source":{"system":"sec-edgar","filing":"0001209191-19-055021","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919119055021/doc4.xml","form_type":"4"}},{"id":3382123,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-11-04T18:06:30.000Z","date":"2019-11-01","kind":"sale","acquired":false,"shares":11403,"price":13.2881,"value":151524.2043,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The reporting person sold 11,403 shares of common stock in anticipation of a potential alternative minimum tax liability resulting from his exercise of a portion of an incentive stock option covering 71,750 shares of common stock on November 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $13.00 to $13.52. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":924943,"source":{"system":"sec-edgar","filing":"0001209191-19-055021","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919119055021/doc4.xml","form_type":"4"}},{"id":3382122,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-11-04T18:06:30.000Z","date":"2019-11-01","kind":"exercise","acquired":true,"shares":11403,"price":1.44,"value":16420.32,"ownership":{"direct":true},"balance_after":936346,"source":{"system":"sec-edgar","filing":"0001209191-19-055021","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919119055021/doc4.xml","form_type":"4"}},{"id":3382121,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-11-04T18:06:30.000Z","date":"2019-10-31","kind":"sale","acquired":false,"shares":28376,"price":12.9886,"value":368564.5136,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person sold 28,376 shares of common stock in anticipation of a potential alternative minimum tax liability resulting from his exercise of a portion of an incentive stock option covering 71,750 shares of common stock on November 1, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $12.70 to $13.32. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":924943,"source":{"system":"sec-edgar","filing":"0001209191-19-055021","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919119055021/doc4.xml","form_type":"4"}},{"id":3382120,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":112440,"kind":"person","name":"CHEN JIN-LONG","position":1,"cik":"0001642996","reported_name":"CHEN JIN-LONG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-11-04T18:06:30.000Z","date":"2019-10-31","kind":"exercise","acquired":true,"shares":28376,"price":1.44,"value":40861.44,"ownership":{"direct":true},"balance_after":953319,"source":{"system":"sec-edgar","filing":"0001209191-19-055021","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1642996/000120919119055021/doc4.xml","form_type":"4"}}]}